Latest Triptorelin Stories
LAUSANNE, Switzerland, May 19, 2015 /PRNewswire/ -- Triptorelin 6-month formulation phase III trial demonstrates good efficacy in terms of pituitary and gonadal suppression
DALLAS, March 6, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2015" therapeutic market research report of
Trelstar® one-, three-, and six-month dosing options now available TORONTO and LAUSANNE, Switzerland, September 30, 2014 /PRNewswire/ -- Trelstar(R) (triptorelin
LAUSANNE, Switzerland, January 13, 2014 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the
WASHINGTON, May 16, 2011 /PRNewswire/ -- A poster entitled, "Time to Progression in Patients with Prostate Cancer: A Comparison of Continuous Degarelix versus Degarelix Following Leuprolide Treatment," is being presented at the American Urological Association 2011 meeting by E.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).